2011 annual financial data
Supernus Pharmaceuticals 2011 Operating margin
Direct answer
Operating margin was -4,701.37%.
Operating income was -37,752,000 USD and net income was 56,003,000 USD.
Operating cash flow was -36,185,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 803,000 USD
- Operating income
- -37,752,000 USD
- Net income
- 56,003,000 USD
- Operating cash flow
- -36,185,000 USD